KA/EN
Register
Medicines reference
Search
Search
Product

Arpalit Neo

Favourites

Permethrin + Fenoxycarb · AVEFLOR, a.s.

3 forms: aerosol / spray, topical (unspecified). In force in Georgia: 3 of 3 (veterinary register).

Do not use on cats. Prevent cats from contacting or grooming a treated dog; follow the exact label for the separation period. Species safety: cats →

Forms and doses3 of 3 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
4.7/1.2 mg/g cutaneous aerosol spray, Aerosol / spray · Dog Dog Ectoparasite Infestation · On the skin: 4.277 ml/kg - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 4.7/1.2მგ/გ
№ 328-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arpalit Neo 4.7/1.2 mg/g cutaneous aerosol spray, Aerosol / spray

150 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.9/10
Situational / acceptable
vetman assessment

Arpalit Neo

4.7/1.2 mg/g cutaneous aerosol spray, 150 ml for dogs
Assessed clinical scopeDog · Full Georgian dog presentation scope: whole-coat treatment of labelled flea, tick, louse and mite ectoparasitoses and their developmental stages with permethrin/fenoxycarb aerosol spray · On the skin
Care settingWhole-coat topical treatment selected after parasite confirmation and a patient, household, handler and environmental risk assessment
vetman score 6.9/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 328-11 · Verified on 21 Oct 2026

A regulated broad whole-coat option with useful four-week flea/tick activity, but it is materially less forgiving than a pipette. Exact coat-dependent dosing, feline lethality, handler exposure and aquatic risk must all be actively managed.

Regulatory and scientific credibility8.7/10

The exact 4.7/1.2 mg/g 150 ml presentation is actively registered in Georgia and has a current EU regulator SPC. Documentation is detailed, but independent exact-combination clinical trials are sparse and the foreign SPC includes additional non-food species beyond the Georgian dog presentation.

Clinical efficacy7.2/10

The label provides broad ectoparasite treatment, immature-stage activity and up to four weeks against fleas and ticks. Permethrin class evidence is credible, but exact permethrin/fenoxycarb comparative evidence is thin and whole-coat underdosing may reduce efficacy and select resistance.

Safety and tolerability5.8/10

The label reports very rare but potentially neurologic and systemic reactions. Cats must not be exposed; aerosol inhalation and skin/eye exposure require PPE and ventilation, fenoxycarb is flagged as a potential human carcinogen, and both actives are hazardous to aquatic life.

Clinical practicality5.5/10

Dose depends on weight, coat length and density and requires whole-body spraying, combing or massage to the skin. Gloves, sometimes eye/respiratory protection, ventilation, 24-hour child exclusion, 48-hour no-bath and two-day no-swim rules make use demanding.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats and prevent cats contacting treated dogs; permethrin exposure can be fatal to cats.
  • Do not use in sick animals, puppies under 2 months, on damaged skin or with hypersensitivity; the foam and 6.0/1.5 mg/g spray are also contraindicated in pregnancy and lactation.
  • Dose and coverage depend on weight, coat length and density; treat the whole coat to the skin and avoid underdosing or empirical interval extension.
  • Use in a well-ventilated area with gloves; avoid inhalation and eye/skin/mucosal exposure. Fenoxycarb is flagged in the label as a potential human carcinogen.
  • Do not combine with other products containing pyrethroids or organophosphates.
  • Prevent licking; keep children away for at least 24 hours, do not bathe for 48 hours and keep the dog out of water for two days.
  • Monitor coat or skin change, vomiting, salivation, diarrhoea, tremor, seizure, abnormal gait, breathing or temperature; bathe with non-insecticidal shampoo and seek veterinary care if signs occur.
Assessment sources
  1. EU UPD 20252025
  2. Georgia NFA register 20262026
  3. Permethrin dog efficacy review2016
  4. Boland & Angles 20102010
  5. EMA ectoparasiticide environment 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Permethrin4.7 mg/g Fenoxycarb1.2 mg/g
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
AVEFLOR, a.s. · Czechia
Manufacturer (register)
AVEFLOR, a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1551, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 4.7/1.2მგ/გ
№ 328-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
Dog
WeightEctoparasite Infestation · On the skin
Any weight 4.277 ml/kg
  • Ectoparasite Infestation · On the skin (single application; repeat no sooner than 1 week): Nominal volume equivalent: the label dose is permethrin 15 mg/kg; at 4.7 mg/g and 1 g per 1.34 ml this is 4.277 ml/kg. Actual use also depends on coat length and density: spray against hair growth from 15-20 cm until lightly moistened, comb through to the skin and do not bathe for 48 hours. One 150 ml can treats about 35 kg. Protection against fleas and ticks lasts up to 4 weeks; for lice or mites, repeat after 1-2 weeks when indicated. DOG USE ONLY in the Georgian presentation: never use on cats and keep cats away from treated animals. Do not use in sick animals, under 2 months, on damaged skin or with hypersensitivity. Pregnancy and lactation require veterinary benefit-risk assessment. Do not combine with other pyrethroid or organophosphate products. Prevent licking and eye/nose exposure; keep children away until dry for at least 24 hours and keep treated animals out of water for 2 days.
Source:
EU UPD 2025
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arpalit Neo 4.7/1.2 mg/g cutaneous spray - Summary of Product Characteristics
EU Union Product Database, 2025
4.8/1.2 mg/g cutaneous foam, Topical (unspecified) - No label dose in the reference yet - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 4.8/1.2მგ/გ
№ 330-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arpalit Neo 4.8/1.2 mg/g cutaneous foam, Topical (unspecified)

150 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.8/10
Situational / acceptable
vetman assessment

Arpalit Neo

4.8/1.2 mg/g cutaneous foam, 150 ml for dogs
Assessed clinical scopeDog · Full dog label: whole-coat treatment of labelled flea, tick, louse and biting-louse ectoparasitoses and their developmental stages with permethrin/fenoxycarb foam · On the skin
Care settingWhole-coat topical treatment selected after parasite confirmation and a patient, household, handler and environmental risk assessment
vetman score 6.8/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 330-11 · Verified on 21 Oct 2026

A legitimate treatment-only whole-coat option, but not a documented monthly preventive. Unmeasured coat-dependent application, absent persistence evidence and substantial feline, handler and environmental precautions keep it situational.

Regulatory and scientific credibility8.6/10

The exact 4.8/1.2 mg/g 150 ml dog foam is actively registered in Georgia and has a current regulator-linked SPC. Documentation is detailed, but independent exact-combination clinical trials are sparse and persistence is explicitly unproven.

Clinical efficacy6.5/10

The combination has plausible adult and immature-stage activity and a broad treatment label, but the label states that duration against individual parasites has not been demonstrated. It should therefore be judged for parasites present at treatment, not assumed to provide a monthly prevention interval.

Safety and tolerability6.0/10

Rare intoxication can include coat loss, vomiting, tremor, convulsion or slowed breathing. Cats, young puppies and pregnant or lactating bitches are excluded; whole-coat handler contact, a pressurised flammable container and aquatic toxicity add material risk.

Clinical practicality5.8/10

The tennis-ball-sized foam amount is adjusted by animal size and spread over the whole body to the skin, without a precise measurable dose or demonstrated retreatment interval. Gloves, ventilation, 24-hour child exclusion and 48-hour no-bath handling are burdensome.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats and prevent cats contacting treated dogs; permethrin exposure can be fatal to cats.
  • Do not use in sick animals, puppies under 2 months, on damaged skin or with hypersensitivity; the foam and 6.0/1.5 mg/g spray are also contraindicated in pregnancy and lactation.
  • Dose and coverage depend on weight, coat length and density; treat the whole coat to the skin and avoid underdosing or empirical interval extension.
  • Use in a well-ventilated area with gloves; avoid inhalation and eye/skin/mucosal exposure. Fenoxycarb is flagged in the label as a potential human carcinogen.
  • Do not combine with other products containing pyrethroids or organophosphates.
  • Prevent licking; keep children away for at least 24 hours, do not bathe for 48 hours and keep the dog out of water for two days.
  • Monitor coat or skin change, vomiting, salivation, diarrhoea, tremor, seizure, abnormal gait, breathing or temperature; bathe with non-insecticidal shampoo and seek veterinary care if signs occur.
Assessment sources
  1. EU UPD 20262026
  2. Georgia NFA register 20262026
  3. Permethrin dog efficacy review2016
  4. Boland & Angles 20102010
  5. EMA ectoparasiticide environment 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Permethrin4.8 mg/g Fenoxycarb1.2 mg/g
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
AVEFLOR, a.s. · Czechia
Manufacturer (register)
AVEFLOR, a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1553, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 4.8/1.2მგ/გ
№ 330-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
6.0/1.5 mg/g cutaneous spray solution, Topical (unspecified) - No label dose in the reference yet - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 6.0/1.5მგ/გ კანის სპრეი, ხსნარი
№ 305-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arpalit Neo 6.0/1.5 mg/g cutaneous spray solution, Topical (unspecified)

150 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.8/10
Situational / acceptable
vetman assessment

Arpalit Neo

6.0/1.5 mg/g cutaneous spray solution, 150 ml for dogs
Assessed clinical scopeDog · Full Georgian dog presentation scope: whole-coat treatment of labelled flea, tick, louse and biting-louse ectoparasitoses and their developmental stages with permethrin/fenoxycarb cutaneous spray · On the skin
Care settingWhole-coat topical treatment selected after parasite confirmation and a patient, household, handler and environmental risk assessment
vetman score 6.8/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 305-11 · Verified on 21 Oct 2026

A regulated broad treatment spray with credible active ingredients but incomplete exact-product persistence evidence. Its whole-coat technique and serious feline, handler and environmental constraints make it a situational rather than first-line convenience choice.

Regulatory and scientific credibility8.7/10

The exact 6.0/1.5 mg/g 150 ml presentation is actively registered in Georgia and has a current EU regulator document. Exact-combination independent trials are sparse, and the foreign record includes some additional non-food species beyond the Georgian dog presentation.

Clinical efficacy6.8/10

The combination has plausible adult and immature-stage activity and a broad treatment label, but the current instruction does not establish a retreatment interval or persistent duration. Class evidence cannot substitute for exact-product residual-efficacy data.

Safety and tolerability5.8/10

Very rare reactions may be neurologic or systemic. Cats, sick animals, young puppies, pregnancy and lactation are excluded; whole-coat spray exposure, handler precautions, flammability and aquatic toxicity materially constrain safe use.

Clinical practicality5.5/10

The amount depends on coat length and density and requires whole-body spraying, combing or massage to the skin without a precise measurable regimen. PPE, ventilation, drying, 24-hour child exclusion, 48-hour no-bath and two-day no-swim rules are demanding.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats and prevent cats contacting treated dogs; permethrin exposure can be fatal to cats.
  • Do not use in sick animals, puppies under 2 months, on damaged skin or with hypersensitivity; the foam and 6.0/1.5 mg/g spray are also contraindicated in pregnancy and lactation.
  • Dose and coverage depend on weight, coat length and density; treat the whole coat to the skin and avoid underdosing or empirical interval extension.
  • Use in a well-ventilated area with gloves; avoid inhalation and eye/skin/mucosal exposure. Fenoxycarb is flagged in the label as a potential human carcinogen.
  • Do not combine with other products containing pyrethroids or organophosphates.
  • Prevent licking; keep children away for at least 24 hours, do not bathe for 48 hours and keep the dog out of water for two days.
  • Monitor coat or skin change, vomiting, salivation, diarrhoea, tremor, seizure, abnormal gait, breathing or temperature; bathe with non-insecticidal shampoo and seek veterinary care if signs occur.
Assessment sources
  1. EU UPD 20262026
  2. Georgia NFA register 20262026
  3. Permethrin dog efficacy review2016
  4. Boland & Angles 20102010
  5. EMA ectoparasiticide environment 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Permethrin6 mg/g Fenoxycarb1.5 mg/g
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
AVEFLOR, a.s. · Czechia
Manufacturer (register)
AVEFLOR, as, Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1532, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: არპალიტ ნეო 6.0/1.5მგ/გ კანის სპრეი, ხსნარი
№ 305-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
Active substance doses, with sources
Active substance Permethrin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
50 mg/kg Dog Maintenance On the skin according to the epidemiological situation
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Advantix 40 mg + 200 mg spot-on solution for dogs (<= 4 kg) - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2026
60 mg/kg Dog Maintenance On the skin not more often than once every 4 weeks
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Effitix 26.8 mg/240 mg spot-on solution for very small dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025

Fenoxycarb: No dose supported by a publicly verifiable source yet

Known Contraindications

  • Critical Permethrin
    Do not use in cases of hypersensitivity to the active substances, or to any of the excipients.
    Sources: VMD SPC · VMD
  • Warning Permethrin (Dog)
    In the absence of available data the veterinary medicinal product should not be used on puppies of less than 7 weeks of age or 1.5 kg of weight. The safety of the product has not been established in dogs younger than 12 weeks of age or in dogs weighing less than 1.5 kg.
    Sources: VMD SPC · VMD
  • Caution Permethrin (Dog)
    Can be used during pregnancy and lactation. The safety of the veterinary medicinal product has not been established in dogs during pregnancy, lactation or in animals intended for breeding. Laboratory studies in rabbits and rats with the excipient N-methyl pyrrolidone have shown evidence of foetotoxic effects. Use only according to the benefit-risk assessment by the responsible veterinarian. The safety of the veterinary medicinal product has not been established during pregnancy and lactation in bitches. Use in pregnancy and lactation only in accordance with professional veterinary advice and a benefit/risk assessment.
    Sources: VMD SPC · VMD
  • Caution Permethrin (Dog)
    Can be used during pregnancy and lactation. Use only according to the benefit-risk assessment by the responsible veterinarian.
    Sources: VMD SPC · VMD

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (80 more) Hide additional products

Same therapeutic group 80

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗